Where Will Hershey Stock Be In 1 Year?
Chocolate stocks used to be the epitome of sleepy stability,…
Buy
76
OXBR Quote, Financials, Valuation and Earnings
Last price:
$2.19
Seasonality move
:
-10.49%
Day range:
$1.75 - $2.38
52-week range:
$1.27 - $5.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.53x
P/B ratio:
2.40x
Volume:
1.4M
Avg. volume:
122.6K
1-year change:
-2.99%
Market cap:
$16.9M
Revenue:
$546K
EPS (TTM):
-$0.33
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Oxbridge Re Holdings has 120.26% upside to fair value with a price target of $5.00 per share.
OXBR vs. S&P 500
-
Over the past 5 trading days, Oxbridge Re Holdings has overperformed the S&P 500 by 18.43% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Oxbridge Re Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oxbridge Re Holdings revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Oxbridge Re Holdings reported revenues of $692K.
Earnings Growth
-
Oxbridge Re Holdings earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Oxbridge Re Holdings reported earnings per share of -$0.02.
Enterprise value:
12.2M
EV / Invested capital:
--
Price / LTM sales:
10.53x
EV / EBIT:
--
EV / Revenue:
8.97x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-17.87x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-12.25%
Net Income Margin (TTM):
-72.12%
Return On Equity:
-21.13%
Return On Invested Capital:
-17.25%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.4M | -$7.7M | $1.4M | -$125K | $692K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$0.22 | -$1.86 | -$0.33 | -$0.15 | -$0.02 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.9M | $3.1M | $1.2M | $1.1M | $5.2M | |
| Total Assets | $8.8M | $17.2M | $16.8M | $7.3M | $10.3M | |
| Current Liabilities | $208K | $387K | -- | -- | $2M | |
| Total Liabilities | $744K | $856K | $1.7M | $2.8M | $3M | |
| Total Equity | $8.1M | $16.3M | $15.2M | $4.5M | $7.2M | |
| Total Debt | $216K | $216K | $172K | $2M | $118K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$900K | -$1.4M | -$684K | -$276K | $272K | |
| Cash From Investing | -$465K | $348K | $395K | $448K | $63K | |
| Cash From Financing | -$163K | $1.7M | $5.6M | $395K | $3.4M | |
| Free Cash Flow | -$905K | -$1.4M | -$684K | -$276K | $272K | |
OXBR
Sector
Market Cap
$16.9M
$640.5M
Price % of 52-Week High
39.07%
89.74%
Dividend Yield
0%
1.97%
Shareholder Yield
-30.23%
4.12%
1-Year Price Total Return
-2.99%
15.07%
Beta (5-Year)
1.581
0.588
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.84
200-day SMA
Sell
Level
$2.81
Bollinger Bands (100)
Sell
Level
1.23 - 3.45
Chaikin Money Flow
Sell
Level
-335.3M
20-day SMA
Buy
Level
$1.72
Relative Strength Index (RSI14)
Buy
Level
67.41
ADX Line
Buy
Level
19.72
Williams %R
Sell
Level
-12.6437
50-day SMA
Buy
Level
$1.70
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
613.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.3663)
Sell
CA Score
(Annual)
Level (-0.9556)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (5.7766)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
Stock Forecast FAQ
In the current month, OXBR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OXBR average analyst price target in the past 3 months is $5.00.
-
Where Will Oxbridge Re Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oxbridge Re Holdings share price will rise to $5.00 per share over the next 12 months.
-
What Do Analysts Say About Oxbridge Re Holdings?
Analysts are divided on their view about Oxbridge Re Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oxbridge Re Holdings is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Oxbridge Re Holdings's Price Target?
The price target for Oxbridge Re Holdings over the next 1-year time period is forecast to be $5.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OXBR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oxbridge Re Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OXBR?
You can purchase shares of Oxbridge Re Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oxbridge Re Holdings shares.
-
What Is The Oxbridge Re Holdings Share Price Today?
Oxbridge Re Holdings was last trading at $2.19 per share. This represents the most recent stock quote for Oxbridge Re Holdings. Yesterday, Oxbridge Re Holdings closed at $2.27 per share.
-
How To Buy Oxbridge Re Holdings Stock Online?
In order to purchase Oxbridge Re Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will KNOT Stock Be In 1 Year?
In the case of KNOT Offshore Partners (KNOP), most headlines…
Why Is Goldman Sachs Stock Up So Much?
Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…
Stock Ideas
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 53x
Buy
60
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
92
BGL alert for Jul 3
Blue Gold [BGL] is down 20.3% over the past day.
Sell
18
CNC alert for Jul 3
Centene [CNC] is down 1.3% over the past day.
Sell
12
MOH alert for Jul 3
Molina Healthcare [MOH] is up 0.3% over the past day.
